NCT02146209View on ClinicalTrials.gov

Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Bacterial Infections
Interventions
DRUG

Metronidazole benzoate

Single oral dose of 400 mg

DRUG

Flagyl 125 mg/5 ml oral suspension

Single oral dose of 500 mg (20 ml suspension)

DRUG

Flagyl 400 mg Tablets

Single oral dose of 400 mg

Trial Locations (1)

963166

International Pharmaceutical Research Center (IPRC), Amman

All Listed Sponsors
lead

Verisfield UK Ltd. Greek Branch

INDUSTRY

NCT02146209 - Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. | Biotech Hunter | Biotech Hunter